Long-term potency preservation following brachytherapy for prostate cancer

BJU International

Volumn 110, Issue 2, 2012, Pages 221-225

  Snyder, Kurt M ^a   Stock, Richard G ^a   Buckstein, Michael ^a   Stone, Nelson N ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen deprivation; Brachytherapy; Potency; Prostate cancer

Indexed keywords

IODINE 125; PALLADIUM 103; PHOSPHODIESTERASE V INHIBITOR;

ADULT; AGE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EVALUATION; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; THERAPY EFFECT;

EID: 84863438775     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10800.x     Document Type: Article

References (20)

1. Sanda MG, Dunn RL, Michalski J et al.Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-61 (Pubitemid 351439226)
2. Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996; 35: 267-72 (Pubitemid 26158747)
3. Zagar TM, Stock RG, Cesaretti JA, Stone NN. Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS. Brachytherapy 2007; 6: 26-33 (Pubitemid 46187327)
4. Stone NN, Stock RG. Prostate brachytherapy: treatment strategies. J Urol 1999; 162: 421-6 (Pubitemid 29434353)
5. Stock RG, Stone NN, Wesson MF, DeWyngaert JK. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 1995; 32: 219-25
6. Stone NN, Ramin SA, Wesson MF, Stock R, Unger P, Klein G. Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate. J Urol 1995; 153: 1555-60
7. Stock RG, Stone NN, Tabert A, Iannuzzi C, DeWyngaert JK. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 1998; 41: 101-8 (Pubitemid 28211308)
8. Stock RG, Stone NN, Lo YC, Malhado N, Kao J, DeWyngaert JK. Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome. Int J Radiat Oncol Biol Phys 2000; 48: 899-906
9. Potters L, Cao Y, Calugaru E, Torre T, Fearn P, Wang XH. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2001; 50: 605-14 (Pubitemid 32519593)
10. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 1995; 22: 209-34
11. Beyer D, Nath R, Butler W et al. American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2000; 47: 273-5 (Pubitemid 30236365)
12. Ho AY, Burri RJ, Cesaretti JA, Stone NN, Stock RG. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75: 16-22
13. Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70
15. Cox DR. Regression models and life-tables. J R Stat Soc Ser B 1972; 34: 187-220
16. Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002; 52: 893-902 (Pubitemid 34223438)
17. Merrick GS, Butler WM, Wallner KE et al. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005; 62: 437-47 (Pubitemid 40704460)
18. Stone NN, Stock RG. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology 2007; 69: 338-42 (Pubitemid 46274929)
19. Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001; 165: 436-9 (Pubitemid 32060431)
20. Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2001; 50: 1235-42 (Pubitemid 32727801)